🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

An important article from BioMADE Chief Manufacturing Officer, Jack Starr, on the emergence of the U.S. bioindustrial revolution: bit.ly/3J43RIx #bioeconomy #biomanufacturing #biotechnology #syntheticbiology #MadeByManus

Georgia was recently named as one of six states for consideration as potential sites to create a network of bioindustrial manufacturing pilot facilities by BioMADE, a Manufacturing Innovation Institute sponsored by the U.S. Department of Defense: bit.ly/4amYpMf

The White House just took a vital step in announcing the launch of the National Bioeconomy Board focused on increasing U.S. competitiveness in #biotechnology and #biomanufacturing: bit.ly/3VzzRLV

Innovation requires both an understanding of what’s come before and the courage to change it. 2024 is a big year for bioalternatives. We invite you to join the transition with us. Stay tuned for more. #biomanufacturing #biotechnology #syntheticbiology #MadeByManus

At Manus, we are accelerating the transition to bioalternatives by delivering the benefits of synthetic biology, today. We're excited to share our vision and expand the possibilities with our customers, partners, and industry peers through our new site: manusbio.com

Join Waleed Nasser and David Tennenhouse from the U.S. National Science Foundation as they discuss their $80 million in funding opportunities that support endeavors specifically aimed at growing the U.S. #bioeconomy. Register now: synbiobeta.zoom.us/webinar/regist… #bioeconomy #syntheticbiology SynBioBeta

To change the #syntheticbiology industry takes purpose, commitment, and an unwavering drive to challenge the status quo. That’s what our new Chief Business Officer, David Muldoon, brings to the table, along with more than 25 years of deep industry and value chain experience.

Manus CTO, Christine Santos, spoke with SynBioBeta about the future of bioalternatives: bit.ly/3U3EGKZ At Manus, we engineer bioalternatives to replicate nature, creating cost-effective, reliable, and sustainable molecules for use in everyday products.

#EarthDay is a powerful reminder that our planet needs us to fight for real, achievable sustainability practices across all industries. We’d love to hear about how your company or industry could benefit from bioalternatives– comment below!

Chief Technology Officer at Manus, Christine Santos, recently sat down with SynBioBeta to discuss the potential benefits of bioalternatives, the future of synthetic biology, and how our BioManufacturing Program is helping address industry challenges: bit.ly/3U8GCSE

Join Manus next week as we take you behind the scenes of SynBioBeta 2024. We’ll be connecting with key players in the industry to discuss bioalternatives and how we deliver the benefits of synthetic biology by bridging the Valley of Death between lab scale and manufacturing.

While we are busy accelerating the transition to bioalternatives, we took a moment to enjoy time with our amazing team of BioHands, the beautiful weather in Augusta, and some free ice cream! #bioeconomy #biomanufacturing #biotechnology #syntheticbiology #MadeByManus

The Manus team is excited to attend the BioMADE 2024 Member Meeting on May 29-31 in Minneapolis, MN. This exciting conference brings together BioMADE members and the U.S. Government to participate in member discussions about the latest trends in technology and more!

Manus CTO, Christine Santos, explains our BioManufacturing Program in-depth and how it can help companies make bioalternatives at scale, enabling them to expand their scale-up and production capacity using our state-of-the-art BioFacility in Augusta: bit.ly/4bYbDAl.

Last week, Manus VP of R&D, Joe Shaw, spoke at SIMB 2024. He touched on key insights and core principles behind Manus’ approach to strain design and metabolic engineering to optimize cell factories using Manus' BioOptimization Cycle™ technology: manusbio.com/science-and-te…

We are excited to announce a strategic partnership, The Natural Sweetener Alliance, with Tate & Lyle to expand access to natural sugar reduction solutions. Learn more about stevia Reb M, the first jointly introduced ingredient, and this partnership: bit.ly/40nGYcF

We are excited to announce that Manus has received a $32.4 million award from the HHS.gov Defense Production Act Title III Program to support the domestic production of critical essential medicines at population-scale: manusbio.com/articles/manus… #biotechnology #biomanufacturing

Industrial biotech, built to scale. This week, Manus and Inscripta, Inc. united to form a new leader in biomanufacturing — delivering real-world impact through scalable bioalternatives. Made to scale. Made to deliver. Made by Manus™ manusbio.com/articles/manus…

Heading to #IFTFirst 2025 next week in Chicago? Let’s connect! Manus will be at Booth #S1265 at the largest global #foodscience and innovation expo, hosted by Institute of Food Technologists (IFT). See you there!

We’re counting down to #IFTFirst 2025 in Chicago! In just a few days, the Manus team will be at booth #S1265, ready to share our summer-ready, sugar-free treats and #sustainable, supply-secure citrus BioIngredients, Made by Manus™. Learn more: manusbio.com/articles/manus…